Notice of Funding Opportunity Purpose
National Institutes of Health
Description
This grant opportunity supports projects that align with the goals of the NINDS and involve studying or developing products such as drugs, biologics, devices, or diagnostics. It also supports research on surgical, behavioral, or rehabilitation therapies.
The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies.
Source
Grant ID
PAR-23-311
Agency
National Institutes of Health
Subcategory/Subagency
National Institute of Neurological Disorders and Stroke
Program
SBIR
Key Dates
Opportunity Released
November 27, 2023
Open for Submission
November 27, 2023
Submission Deadline
September 5, 2026
Application Window Closes
September 5, 2026
Eligibility
The following categories of applicants are invited to apply:
- For-Profit Organizations: United States Small Business Concerns (SBCs) — organized for profit; place of business in the U.S.; operates primarily in the U.S. or contributes significantly to the U.S. economy; including proprietorships, partnerships, LLCs, corporations, associations, trusts, cooperatives
- Joint ventures of eligible SBCs — each party must meet SBIR/SBIR ownership requirements; joint venture must have <50% participation by foreign business entities
- SBCs majority-owned by multiple venture capital operating companies, hedge funds, or private equity firms (SBIR-only; subject to ownership limits and other SBA rules)
- Tribal- or Native-owned SBCs — Small businesses owned by an Indian tribe, Alaska Native Corporation (ANC), or Native Hawaiian Organization (NHO)
Similar opportunities
- Notice of Funding Opportunity for Small Business Innovation Research (SBIR) Grant Applications
National Institutes of Health
- NINDS K22 Career Transition Award to Promote Diversity in Neuroscience Research
National Institutes of Health
- Limited Competition: Renewal Applications for NINDS-supported Clinical Trial Cooperative Agreement Awards (U01)
National Institutes of Health
- Notice of Funding Opportunity (NOFO) for Clinical Trials
National Institutes of Health
- Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics): Biologics-based Therapy Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
National Institutes of Health